Curosurf.
D000818:Animals; D001688:Biological Products; D001919:Bradycardia / Q000139:chemically induced; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D005252:Fees, Pharmaceutical; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D007231:Infant, Newborn; D007234:Infant, Premature; D007442:Intubation, Intratracheal; D008170:Lung Compliance / Q000187:drug effects; D010743:Phospholipids; D011663:Pulmonary Surfactants / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D051381:Rats; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy
D001688:Biological Products; D010743:Phospholipids; D011663:Pulmonary Surfactants; C068291:poractant alfa